Eric M Dube

CIK 1763494 · CHIEF EXECUTIVE OFFICER · last filed 2026-05-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$22.53M

Companies

3

Total Filings

38

Lifetime Open-Market Net

-$21.24M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TVTX CHIEF EXECUTIVE OFFICER 432,886 $52.04 $22.53M -$20.92M 31 2026-05-06
OnKure Therapeutics, Inc. (RPHM) Delisted Director $18.20 $0 2 2023-06-08
Travere Therapeutics, Inc. (RTRX) Delisted Chief Executive Officer 96,260 -$317.4K 5 2020-09-22

Recent Filings · Page 4 of 4

38 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-01-28 TVTX Grant (A) $0 EDGAR
2021-01-25 TVTX Grant (A) +57,260 $0 EDGAR
2021-01-07 TVTX Sell (S) −6,876 -$184.5K EDGAR
2020-09-22 Travere Therapeutics, Inc. (RTRX) Delisted Mixed +17,195 -$208.3K EDGAR
2020-01-31 Travere Therapeutics, Inc. (RTRX) Delisted Grant (A) +35,000 $0 EDGAR
2020-01-08 Travere Therapeutics, Inc. (RTRX) Delisted Sell (S) −7,500 -$109.0K EDGAR
2019-05-10 Travere Therapeutics, Inc. (RTRX) Delisted Grant (A) $0 EDGAR
2019-01-08 Travere Therapeutics, Inc. (RTRX) Delisted Grant (A) +50,000 $0 EDGAR
Showing 3138 of 38
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.